JP2013540702A5 - - Google Patents

Download PDF

Info

Publication number
JP2013540702A5
JP2013540702A5 JP2013524419A JP2013524419A JP2013540702A5 JP 2013540702 A5 JP2013540702 A5 JP 2013540702A5 JP 2013524419 A JP2013524419 A JP 2013524419A JP 2013524419 A JP2013524419 A JP 2013524419A JP 2013540702 A5 JP2013540702 A5 JP 2013540702A5
Authority
JP
Japan
Prior art keywords
cyclic peptide
linked cyclic
aminooxy functionalized
met
met linked
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013524419A
Other languages
English (en)
Japanese (ja)
Other versions
JP6014592B2 (ja
JP2013540702A (ja
Filing date
Publication date
Priority claimed from GBGB1013808.9A external-priority patent/GB201013808D0/en
Application filed filed Critical
Publication of JP2013540702A publication Critical patent/JP2013540702A/ja
Publication of JP2013540702A5 publication Critical patent/JP2013540702A5/ja
Application granted granted Critical
Publication of JP6014592B2 publication Critical patent/JP6014592B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013524419A 2010-08-18 2011-08-11 ペプチド放射性トレーサー組成物 Active JP6014592B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1013808.9A GB201013808D0 (en) 2010-08-18 2010-08-18 Peptide radiotracer compositions
GB1013808.9 2010-08-18
PCT/EP2011/063890 WO2012022676A1 (en) 2010-08-18 2011-08-11 Peptide radiotracer compositions

Publications (3)

Publication Number Publication Date
JP2013540702A JP2013540702A (ja) 2013-11-07
JP2013540702A5 true JP2013540702A5 (https=) 2014-09-18
JP6014592B2 JP6014592B2 (ja) 2016-10-25

Family

ID=42938098

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013524419A Active JP6014592B2 (ja) 2010-08-18 2011-08-11 ペプチド放射性トレーサー組成物

Country Status (19)

Country Link
US (1) US9533059B2 (https=)
EP (1) EP2605802B1 (https=)
JP (1) JP6014592B2 (https=)
KR (1) KR101853993B1 (https=)
CN (1) CN103153350B (https=)
AU (1) AU2011290856B2 (https=)
BR (1) BR112013003469A2 (https=)
CA (1) CA2807491C (https=)
CL (1) CL2013000483A1 (https=)
ES (1) ES2626410T3 (https=)
GB (1) GB201013808D0 (https=)
IL (1) IL224463A (https=)
MX (1) MX348733B (https=)
MY (1) MY163136A (https=)
NZ (1) NZ606466A (https=)
PH (1) PH12013500270A1 (https=)
RU (1) RU2594167C2 (https=)
SG (1) SG187878A1 (https=)
WO (1) WO2012022676A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201103696D0 (en) 2011-03-04 2011-04-20 Ge Healthcare Ltd Technetium labelled peptides
GB201121914D0 (en) 2011-12-20 2012-02-01 Ge Healthcare Ltd Method for patient selection
GB201209082D0 (en) * 2012-05-24 2012-07-04 Ge Healthcare Ltd Purification method
GB201221266D0 (en) * 2012-11-27 2013-01-09 Ge Healthcare Ltd Aldehyde compositions
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
GB201322451D0 (en) * 2013-12-18 2014-02-05 Ge Healthcare Ltd Purification method and compositions
GB201322456D0 (en) * 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
US20190151483A1 (en) * 2016-07-25 2019-05-23 The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv Methods of making 18f-labeled precursors and peptides, labeled c-met binding peptides, and methods of use thereof
GB201804835D0 (en) * 2018-03-26 2018-05-09 Ge Healthcare As Formulation and method of preparation
GB2589398B (en) * 2019-06-14 2023-02-15 Edinburgh Molecular Imaging Ltd Compounds and methods of use
GB201915206D0 (en) 2019-10-21 2019-12-04 Ge Healthcare Ltd Use of cyclodextrins as a radiostabilizer
SE2050387A1 (en) * 2020-04-06 2021-10-07 Pvac Medical Tech Ltd Labelled substance and methods of detection of inflammation and infection using said substance
TW202509086A (zh) * 2021-03-22 2025-03-01 日商肽夢想股份有限公司 c-Met蛋白質結合肽複合物
GB202105950D0 (en) * 2021-04-26 2021-06-09 Ge Healthcare Ltd Analytical HPLC

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5961955A (en) * 1997-06-03 1999-10-05 Coulter Pharmaceutical, Inc. Radioprotectant for peptides labeled with radioisotope
AU2002357388A1 (en) 2001-12-27 2003-07-24 The United States Of America, As Represented By The Department Of Veterans Affairs Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor
PT2949658T (pt) * 2003-03-03 2018-10-18 Bracco Suisse Sa Péptidos que ligam especificamente o recetor de hgf (cmet) e utilizações dos mesmos
GB0305704D0 (en) * 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
GB0420344D0 (en) * 2004-09-14 2004-10-13 Amersham Plc Diagnostic compounds
EP2043672A4 (en) * 2006-07-07 2009-10-21 Univ Leland Stanford Junior SELECTIVE INHIBITORS OF CASPASES
GB0615211D0 (en) 2006-07-31 2006-09-06 Ge Healthcare Uk Ltd Asymmetric flouro-substituted polymethine dyes
JP5603074B2 (ja) 2006-09-08 2014-10-08 ピラマル イメージング ソシエテ アノニム 18f標識物質のための化合物と方法
EP2099499A2 (en) 2006-12-13 2009-09-16 GE Healthcare AS Synthesis of a radiofluorinated peptide using microwave activation technology
EP2114464A2 (en) * 2006-12-28 2009-11-11 GE Healthcare AS Radiofluorination methods
MX2009009291A (es) 2007-03-01 2009-12-14 Bayer Schering Pharma Ag Compuestos activos biologicamente marcados con fluoro-benzoilo 18f como agentes de diagnostico por imagenes asi como precursores de benzotriazol-1-iloxi-benzoilo, 2,5-dioxo-pirrolidin-1-iloxi benzoilo y trimetilamonio benzoilo.
KR101578225B1 (ko) 2007-05-16 2015-12-17 지이 헬스케어 에이에스 영상화를 위한 표지된 hgf 결합성 펩티드
GB0718957D0 (en) * 2007-09-28 2007-11-07 Ge Healthcare Ltd Optical imaging agents
GB0718967D0 (en) * 2007-09-28 2007-11-07 Ge Healthcare Ltd Peptide imaging agents
GB0716897D0 (en) 2007-08-30 2007-10-10 Univ Muenchen Tech Cancer imaging and treatment
GB0803477D0 (en) 2008-02-26 2008-04-02 Ge Healthcare As Therapy selection method

Similar Documents

Publication Publication Date Title
JP2013540702A5 (https=)
JP2013525942A5 (https=)
JP2013514381A5 (https=)
JP2015503422A5 (https=)
JP2011170856A5 (https=)
JP2012143233A5 (https=)
JP2015520667A5 (https=)
JP2010219032A5 (https=)
JP2016512050A5 (https=)
JP2013181136A5 (ja) ポリイミド前駆体組成物、ポリイミド成形体、及び画像形成装置
JP2012531046A5 (https=)
JP2012190484A5 (https=)
JP2015512729A5 (https=)
JP2015525757A5 (https=)
JP2014102408A5 (https=)
JP2014501485A5 (https=)
JP2013173781A5 (https=)
JP2015528502A5 (https=)
JP2015504870A5 (https=)
JP2014516397A5 (https=)
JP2014517802A5 (https=)
JP2012098988A5 (https=)
JP2015501646A5 (https=)
IL230635A0 (en) A novel 1,2,3,4-tetrahydroquinoline derivative useful for the treatment of diabetes
JP2013543797A5 (https=)